Its deprivation complemented by the loss of ovarian estrogens may be the primary reason for the recurrence suppression and the reduced breast cancer mortality post-oophorectomy in BRCA1/2 carriers with ER-positive or ER-negative nonmetastatic breast cancer. This evidence concerns the gene BRCA1 and breast cancer.